These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 455894)

  • 21. Barbiturate physical dependence in mice: effects of neuroleptics and diazepam on the withdrawal syndrome.
    Belknap JK
    Clin Toxicol; 1978; 12(4):427-34. PubMed ID: 26494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenobarbital compared to benzodiazepines in alcohol withdrawal treatment: A register-based cohort study of subsequent benzodiazepine use, alcohol recidivism and mortality.
    Askgaard G; Hallas J; Fink-Jensen A; Molander AC; Madsen KG; Pottegård A
    Drug Alcohol Depend; 2016 Apr; 161():258-64. PubMed ID: 26922279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case Report of Physiologic Phenibut Dependence Treated With a Phenobarbital Taper in a Patient Being Treated With Buprenorphine.
    Brunner E; Levy R
    J Addict Med; 2017; 11(3):239-240. PubMed ID: 28441273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenobarbital Monotherapy for the Management of Alcohol Withdrawal Syndrome in Surgical-Trauma Patients.
    Ammar MA; Ammar AA; Rosen J; Kassab HS; Becher RD
    Ann Pharmacother; 2021 Mar; 55(3):294-302. PubMed ID: 32830517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenobarbital treatment in a patient with resistant alcohol withdrawal syndrome.
    Hayner CE; Wuestefeld NL; Bolton PJ
    Pharmacotherapy; 2009 Jul; 29(7):875-8. PubMed ID: 19558262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of Atrium 300 in the withdrawal of alcoholic patients].
    Fontan M; Taine D
    Therapeutique; 1973; 49(7):463-6. PubMed ID: 4595358
    [No Abstract]   [Full Text] [Related]  

  • 27. EFFECT OF CHRONIC ADMINISTRATION AND WITHDRAWAL OF BARBITURATES UPON DRINKING IN THE RAT.
    SCHMIDT H; KLEINMAN KM
    Arch Int Pharmacodyn Ther; 1964 Sep; 151():142-9. PubMed ID: 14205407
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety and effectiveness of a fixed-dose phenobarbital protocol for inpatient benzodiazepine detoxification.
    Kawasaki SS; Jacapraro JS; Rastegar DA
    J Subst Abuse Treat; 2012 Oct; 43(3):331-4. PubMed ID: 22285834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenobarbital versus clonazepam for sedative-hypnotic taper in chronic pain patients. A pilot study.
    Sullivan M; Toshima M; Lynn P; Roy-Byrne P
    Ann Clin Psychiatry; 1993 Jun; 5(2):123-8. PubMed ID: 8348204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Major medical problems and detoxification treatment of parenteral drug-abusing alcoholics.
    Novick DM
    Adv Alcohol Subst Abuse; 1984; 3(4):87-105. PubMed ID: 6391110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pharmacological approach to outpatient benzodiazepine detoxification.
    Hayner GN; Inaba DS
    J Psychoactive Drugs; 1983; 15(1-2):99-104. PubMed ID: 6136577
    [No Abstract]   [Full Text] [Related]  

  • 32. Phenobarbital disposition in the neonate.
    Garrettson LK
    Addict Dis; 1975; 2(1-2):179-85. PubMed ID: 1163361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barbiturate dependence and drug preference.
    Tang M; Ahrendsen K; Falk JL
    Pharmacol Biochem Behav; 1981 Mar; 14(3):405-8. PubMed ID: 7195034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic dosing of phenobarbital in the treatment of alcohol withdrawal syndrome.
    Ives TJ; Mooney AJ; Gwyther RE
    South Med J; 1991 Jan; 84(1):18-21. PubMed ID: 1986421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linear correlation between phenobarbital dose and concentration in alcohol withdrawal patients.
    Tangmose K; Nielsen MK; Allerup P; Ulrichsen J
    Dan Med Bull; 2010 Aug; 57(8):A4141. PubMed ID: 20682131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sedative-hypnotic tolerance testing and withdrawal comparing diazepam to barbiturates.
    Perry PJ; Stambaugh RL; Tsuang MT; Smith RE
    J Clin Psychopharmacol; 1981 Sep; 1(5):289-96. PubMed ID: 7334143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Withdrawal symptoms from chronic use of low-dose barbiturates.
    Epstein RS
    Am J Psychiatry; 1980 Jan; 137(1):107-8. PubMed ID: 7352542
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of the psychosyndrome of alcoholic withdrawal using Atrium].
    Descloux A
    Rev Med Suisse Romande; 1971 Jan; 91(1):57-62. PubMed ID: 5164795
    [No Abstract]   [Full Text] [Related]  

  • 39. Barbiturate withdrawal and magnesium deficiency in mice.
    Belknap JK; Berg JH; Ondrusek G; Waddingham S
    Psychopharmacology (Berl); 1978 Dec; 59(3):299-303. PubMed ID: 104334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management and treatment of gamma butyrolactone withdrawal syndrome: a case report and review.
    Ghio L; Cervetti A; Respino M; Belvederi Murri M; Amore M
    J Psychiatr Pract; 2014 Jul; 20(4):294-300. PubMed ID: 25036586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.